Janvier 2026 Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)
Janvier 2026 A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH